Navigation Links
Med-Emerg International Inc. reports improved income from continuing operations

TORONTO, May 12 /PRNewswire-FirstCall/ - Med-Emerg International Inc. (OTCBB - MDER), announced today that revenue from continuing operations, for the three months ended March 31, 2008 were $5.5 million compared to $4.8 million for the same period in 2007 (all amounts are $US unless otherwise stated). For the three month period, earnings before depreciation, amortization, interest and taxes (EBITDA) improved to $179K from a loss of ($106K) in 2007. The improvement in EBITDA arose largely as a result of improved performance in the Infusions Services division. Losses in Pain Management decreased to ($201K) in 2008 from ($234K) in 2007. The Staffing Solutions division reported income of $9K compared to a loss of ($27K) in 2007.

The Company reported a Loss attributable to common shareholders in the quarter of ($6K) ($0.000 per share) in 2008, compared to a loss of ($287K) ($0.005 per share) in 2007.
The Company's financial statement information is summarized below:

(US$000's except share information) Three Months Ended

March 31


2008 2007

Revenue 5,465 4,822

EBITDA 179 (106)

Income (loss) from continuing operations 81 (175)

Loss from discontinued operations (87) (113)

Net income (loss) attributable to common

shareholders (6) (287)

Net income (loss) per common share (basis and


Continuing operations 0.001 (0.003)

Discontinued operations (0.001) (0.002)

Weighted average shares outstanding, basic

(millions) 58,277,696 58,277,696


March December 31,

31, 2008 2007


Balance Sheet Data: --------------------------

Working Capital Surplus 2,436 2,472

Total Assets 7,440 7,529

Long-term debt 397 445

Shareholders' equity - Canadian GAAP 837 880

Shareholders' equity - US GAAP 802 926

MedEmerg specializes in the coordination and delivery of health care services in Canada and overseas. These services include an integrated chronic pain management program, community-based infusion centers and health human resource management, including physician and nurse staffing.

All statements included in this press release that are not statements of historical fact are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "plan", "expect", "believe", "intend", "anticipate", "forecast", "target", "estimate" and similar expressions identify forward-looking statements. Forward-looking statements are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward-looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These risks and uncertainties are outlined in the Company's Annual Report on Form 10-K for 2007, and such other documents as are filed with the Securities and Exchange Commission from time to time. The Company does not undertake to review or update these forward-looking statements. The Company qualifies all of the information contained in this press release, and particularly its forward-looking statements, by these cautionary statements.

SOURCE Med-Emerg International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, ... country to celebrate their sobriety and show through pictures what a positive difference ... photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy Products, ... heating products business. Cozy Products explains what this means for business moving forward. , ... the Cozy Products business model: to sell personal heaters that reduce energy consumption, are ...
(Date:11/25/2015)... Livonia, MI (PRWEB) , ... November 25, 2015 , ... ... at Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the ... the medical and surgical intensive care units (totaling 30 beds) from May 2014 through ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... found that regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. ... , She developed the patent-pending RECOVERY BRA for added comfort and support. The ...
(Date:11/25/2015)... ... , ... Since its launch in 2012, the Regenestem brand ... therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent and ... , Organizations are required to hold a registered trademark in order to make ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 24, 2015  Thanks to a donor with a ... Medical Center,s Sister Diane Grassilli Center for Women,s Health ... San Francisco . ... forward with a gift of $617,320 that allowed the ... with Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) ...
(Date:11/24/2015)... , Nov. 24, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York.  The public is welcome to ... the Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  ... December 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... announced today that the first patient has been enrolled ... a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... Phase 1/2 clinical trial, ESSA intends to demonstrate the ...
Breaking Medicine Technology: